Deutsch English Français

Contact

EP0651803

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP0651803

EP0651803 - PROTEIN EXPRESSION SYSTEM [Right-click to bookmark this link]
Status	Patent revoked Status updated on 12.07.2013 Database last updated on 11.04.2026
Most recent event Tooltip	17.04.2015	Change - lapse in a contracting state	published on 20.05.2015 [2015/21]
Applicant(s)	For all designated states CELLTECH THERAPEUTICS LIMITED 208 Bath Road Slough Berkshire SL1 3WE / GB
	[N/P]
Former [1997/05]	For all designated states CELLTECH THERAPEUTICS LIMITED 216 Bath Road Slough, Berkshire SL1 4EN / GB
Former [1995/19]	For all designated states CELLTECH LIMITED 216 Bath Road Slough Berkshire SL1 4EN / GB
Inventor(s)	01 / WEIR, Andrew Neil Charles 200 Maypole Road Taplow, Maidenhead, Berkshire SL6 0NF / GB
	02 / MOUNTAIN, Andrew Manor Cottage, Barkham Street Barham, Wokingham, Berkshire RG11 4PS / GB
	[1995/19]
Representative(s)	Hallybone, Huw George Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [1995/19]	Hallybone, Huw George CARPMAELS AND RANSFORD 43 Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	93917891.9	22.07.1993
	[1995/19]
	WO1993GB01547
Priority number, date	GB19920015541	22.07.1992 Original published format: GB 9215541
	[1995/19]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9402607
	Date:	03.02.1994
	Language:	EN
	[1994/04]
	Type:	A1 Application with search report
	No.:	EP0651803
	Date:	10.05.1995
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.02.1994 takes the place of the publication of the European patent application.
	[1995/19]
	Type:	B1 Patent specification
	No.:	EP0651803
	Date:	02.05.1997
	Language:	EN
	[1997/18]
Search report(s)	International search report - published on:	EP	03.02.1994
Classification	IPC:	C12N15/13, C12N15/62, C12N15/70, C12P21/08, C07K2/00	[1997/18]
	CPC:	C12N15/70 (EP,US); C07K16/461 (EP,US); C07K2317/24 (EP,US); C07K2319/035 (EP,US); C07K2319/33 (EP,US); C07K2319/55 (EP,US)
	Former IPC [1995/19]	C12N15/13, C12N15/62, C12N15/70, C12P21/08, C07K15/28
Designated contracting states	CH, DE, FR, GB, LI [1995/19]
Title	German:	EXPRESSIONSSYSTEM FÜR PROTEINE	[1995/19]
	English:	PROTEIN EXPRESSION SYSTEM	[1995/19]
	French:	SYSTEME D'EXPRESSION DE PROTEINES	[1995/19]
Entry into regional phase	21.02.1995	National basic fee paid
	21.02.1995	Designation fee(s) paid
	21.02.1995	Examination fee paid
Examination procedure	22.02.1994	Request for preliminary examination filed International Preliminary Examining Authority: EP
	21.02.1995	Examination requested [1995/19]
	16.09.1996	Despatch of communication of intention to grant (Approval: Yes)
	29.10.1996	Communication of intention to grant the patent
	12.11.1996	Fee for grant paid
	12.11.1996	Fee for publishing/printing paid
Opposition(s)	Opponent(s)	01 29.01.1998 13.02.1998 ADMISSIBLE Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco CA 94080-4990 / US Opponent's representative Armitage, Ian Michael Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB
		02 02.02.1998 13.02.1998 ADMISSIBLE Monsanto Company 800 North Lindbergh Boulevard St.Louis, Missouri 63166 / US Opponent's representative Jaenichen, Hans-Rainer Vossius & Partner Postfach 86 07 67 81634 München / DE
		03 02.02.1998 13.02.1998 ADMISSIBLE Novartis Vaccines and Diagnostics, Inc. 1209 Orange Street City of Wilmington County of New Castle / US Opponent's representative Woods, Geoffrey Corlett J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
		[N/P]
	Former [2007/30]
	Opponent(s)	01 29.01.1998 13.02.1998 ADMISSIBLE Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco California 94080 / US Opponent's representative Armitage, Ian Michael Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
		02 02.02.1998 13.02.1998 ADMISSIBLE Monsanto Company 800 North Lindbergh Boulevard St.Louis, Missouri 63166 / US Opponent's representative Jaenichen, Hans-Rainer Vossius & Partner Postfach 86 07 67 81634 München / DE
		03 02.02.1998 13.02.1998 ADMISSIBLE Novartis Vaccines and Diagnostics, Inc. 1209 Orange Street City of Wilmington County of New Castle / US Opponent's representative Woods, Geoffrey Corlett J.A. KEMP & CO. Gray's Inn 14 South Square London WC1R 5JJ / GB
	Former [2004/45]
	Opponent(s)	01 29.01.1998 13.02.1998 ADMISSIBLE Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco California 94080 / US Opponent's representative Armitage, Ian Michael Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
		02 02.02.1998 13.02.1998 ADMISSIBLE Monsanto Company 800 North Lindbergh Boulevard St.Louis, Missouri 63166 / US Opponent's representative Jaenichen, Hans-Rainer Vossius & Partner Postfach 86 07 67 81634 München / DE
		03 02.02.1998 13.02.1998 ADMISSIBLE Chiron Corporation 4560 Horton Street Emeryville, California 94608-2917 / US Opponent's representative Woods, Geoffrey Corlett J.A. KEMP & CO. Gray's Inn 14 South Square London WC1R 5JJ / GB
	Former [1998/14]
	Opponent(s)	01 29.01.1998 13.02.1998 ADMISSIBLE Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco California 94080 / US Opponent's representative Armitage, Ian Michael Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
		02 02.02.1998 13.02.1998 ADMISSIBLE Monsanto Company 800 North Lindbergh Boulevard St.Louis, Missouri 63166 / US Opponent's representative Jaenichen, Hans-Rainer Vossius & Partner Postfach 86 07 67 81634 München / DE
		03 02.02.1998 13.02.1998 ADMISSIBLE Chiron Corporation 4560 Horton Street Emeryville, California 94608 / US Opponent's representative Irvine, Jonquil Claire J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB
	Former [1998/13]
	Opponent(s)	01 29.01.1998 13.02.1998 ADMISSIBLE Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco California 94080 / US Opponent's representative Armitage, Ian Michael Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
	23.03.1998	Invitation to proprietor to file observations on the notice of opposition
	02.12.1998	Reply of patent proprietor to notice(s) of opposition
	15.03.2001	Date of oral proceedings
	03.07.2001	Despatch of minutes of oral proceedings
	02.08.2001	Despatch of communication that the patent will be revoked
	01.07.2004	Legal effect of revocation of patent [2004/53]
	27.04.2007	Despatch of a communication from the opposition division (Time limit: M10)
	07.01.2008	Reply to a communication from the opposition division
	24.11.2009	Date of oral proceedings
	23.12.2009	Despatch of minutes of oral proceedings
	23.12.2009	Despatch of communication that the patent will be revoked
	28.05.2013	Legal effect of revocation of patent [2013/33]
Appeal following opposition	02.03.2010	Appeal received No. T0520/10
	29.04.2010	Statement of grounds filed
	11.06.2013	Result of appeal procedure: closure of the opposition procedure
	15.03.2001	Appeal received No. T0882/01
	06.12.2001	Statement of grounds filed
	01.07.2004	Result of appeal procedure: continuation of opposition procedure
	06.05.2013	Invitation to file observations in an appeal (Time limit: M02) [2013/19]
	28.05.2013	Date of receipt of observations in an appeal [2013/22]
Fees paid	Renewal fee
	21.02.1995	Renewal fee patent year 03
	11.07.1996	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY] E.M. WRIGHT ET AL.: "Dual-origin plasmids containing an amplifiable ColE1 ori; temperature-controlled expression of cloned genes", GENE, vol. 49, no. 3, 1986, ELSEVIER PUBLISHERS, N.Y., U.S.;, pages 311 - 321, XP023543441, DOI: doi:10.1016/0378-1119(86)90367-7 [X] 1-3,8,10 * page 313, column L, line 38 - line 45 * * page 320, column R, line 17 - line 20 * [Y] 4-7,9 DOI: http://dx.doi.org/10.1016/0378-1119(86)90367-7
		[Y] PLASMIDS IN BACTERIA ; EDITORS: D.R. HELINSKI ET AL., 1985, PLENUM PRESS, NEW YORK, US;, pages 383 - 395 [Y] 4-7,9 * S.N. COHEN ET AL. : PARTITIONING OF THE pSC101 PLASMID DURING CELL DIVISION; page 387, line 25 - page 389, line 1 * * page 389, line 1, paragraph 4 - line 9, paragraph 4; table 2 *
		[Y] E.-L. WINNACKER ET AL., GENE UND KLONE, 1984, VERLAG CHEMIE, WEINHEIM, BRD;, pages 110 - 115 [Y] 4-7,9 * 4.1. PLASMIDE * * page 113, column R, line 9 - line 16 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.